首页> 外国专利> Tetrahidropiran Spiro pirrolidinonas piperidinonas replaced and Pharmaceutical compositions containing them, and Use thereof in the treatment and / or prevention of CNS diseases, such as Alzheimer's and Parkinson's, among others.

Tetrahidropiran Spiro pirrolidinonas piperidinonas replaced and Pharmaceutical compositions containing them, and Use thereof in the treatment and / or prevention of CNS diseases, such as Alzheimer's and Parkinson's, among others.

机译:替换四核吡喃螺旋吡咯烷菌和含有它们的药物组合物,及其在治疗和/或预防中枢神经系统疾病例如阿尔茨海默氏病和帕金森氏病中的用途。

摘要

The compounds in this application are modulators of the H3 receptor and are therefore useful as pharmaceutical preparations, especially in the treatment and / or prevention of various diseases regulated by the H3 receptor, including those related to the central nervous system. Claim 1: a formula compound (1), wherein m is 1 or 2; n is 1 or 2; P is 1 or 2; R1 is hydrogen, C1-4 tar, CF3, c1-4-c1-4-tar, R2 is hydrogen, halogen, C1-4 tar or CF3; or salt or its enantiomer or enantiomer.
机译:本申请中的化合物是H3受体的调节剂,因此可用作药物制剂,特别是在治疗和/或预防受H3受体调节的各种疾病中,包括与中枢神经系统有关的疾病。 2.根据权利要求1所述的式(1)的化合物,其中,m为1或2。 n为1或2; P是1或2; R 1为氢,C 1-4焦油,CF 3,c 1-4 -c 1-4焦油,R 2为氢,卤素,C 1-4焦油或CF 3;或盐或其对映体或对映体。

著录项

  • 公开/公告号AR074467A1

    专利类型

  • 公开/公告日2011-01-19

    原文格式PDF

  • 申请/专利权人 SANOFI-AVENTIS;

    申请/专利号AR2009P104667

  • 发明设计人

    申请日2009-12-03

  • 分类号C07D491/107;A61K31/407;A61K31/438;A61K31/35;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/16;A61P25/02;A61P25/08;

  • 国家 AR

  • 入库时间 2022-08-21 18:07:27

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号